Peter Marks

Company: FDA

Job title: Director, CBER

Seminars:

Expediting the Development & Approval of Your Gene Therapies 9:30 am

• Insights on recent efforts to streamline the regulatory process for gene therapies • Strategies for working effectively with the FDA to navigate the regulatory landscape • Key trends and upcoming changes that will impact gene therapy development and approvalRead more

day: Conference Day One pt 1